«OTVETSTVENNOE SAMOLEChENIE» PATsIENTOV S IZZhOGOY


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

This article is devoted to the concept of «responsible self-treatment» of patients with heartburn and discusses the requirements for OTC (OTC; Over-the-Counter) drugs, and compares various schemes of symptomatic therapy using antacids, H2-blockers, prokinetics, and proton pump inhibitors. Based on the pharmacokinetic and pharmacodynamic characteristics and results of clinical trials, the efficacy and safety of different proton pump inhibitors used in the «responsible self-treatment» of patients with reflux disease are characterized.

Толық мәтін

Рұқсат жабық

Авторлар туралы

V. Simanenkov

S. Tikhonov

Әдебиет тізімі

  1. Розен Р., Быков А., Шустова Г. Ответственное самолечение: веление времени. Экономический вестник фармации. 2003; 8: 23-25.
  2. Материалы Коллегии МЗ РФ от 18.03.2003. Доступно на http://www.rosminzdrav.ru.
  3. Лекарственные средства и деньги. Цены, доступность и сдерживание затрат. Пер. с англ. / Под ред. П.А. Воробьева. М., 2006. 213 с.
  4. Noyce P.R. Likelihood of reporting adverse events in community pharmacy: an experimental study. Qual Saf Health Care. 2006; 15(1): 48-52.
  5. Лазебник Л.Б., Машарова А.А., Бордин Д.С. и др. Результаты многоцентрового исследования «Эпидемиология Гастроэзофагеальной РЕфлюксной болезни в России» («МЭГРЕ»). Терапевтический архив. 2011; 1: 45-50.
  6. Исаков В.А. Анализ распространённости изжоги: национальное эпидемиологическое исследование взрослого городского населения (АРИАДНА). Эксп. клин. гастроэнтерол. 2008; 1: 20-30.
  7. Vakil N., van Zanden S. V., Kahrilas P., et al. The Monreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus. Am. J. Gastroenterol. 2006; 101: 1900-20.
  8. Sleisenger M.H., Feldman M., L.S. Friedman L.S. Sleisenger and Fordtran"s Gastrointestinal and Liver Disease. Saunders, 2006. 2889 р.
  9. Lagergren J. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. Engl. J. Med. 1999; 340(11): 825-31.
  10. Wahlqvist P., Carisson J., W. Stahlhammar. Measuring lost productivity in patients with gastrooesophageal reflux disease using a productivity questionnaire (WPAI-GORD). Medical Decision Making. 1999; 19: 532
  11. Coping with common GI symptoms in the community. 2013 WGO global guidelines common GI symptoms. Доступно на http://www.world-gastroenterology.org.
  12. Доступно на http://www.imshealth.com/portal/site/imshealth.
  13. Доступно на http://mainehealthindex.org.
  14. Tytgat G. New algorithm for the treatment of gastro-oesophageal reflux disease. Aliment.Pharmacol. Ther. 2009; 80: 226-34.
  15. Fendrick A.M. Self-selection and use patterns of over-the-counter omeprazole for frequent heartburn. Clin. Gastroenterol. Hepatol. 2004; 2(1): 17-21.
  16. Van Pinxteren B. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst. Rev. 2006.
  17. Tran T., Lowry A. M., El-Serag H.B. Metaanalysis: the efficacy of over-the-counter gastro-oesophageal reflux disease therapies. Aliment Pharmacol Ther. 2006; 25: 143-53.
  18. Wolfe M.M., Soll A.H. The physiology of gastric acid secretion. N. Engl. J. Med. 1988; 319: 1707-15.
  19. Белоусов Ю.Б., Моисеев В.С., Лепахин В.Х. Клиническая фармакология и фармакотерапия. М., 2000. 410 с.
  20. Haag Y. Management of Reflux Symptoms with Over-the-Counter Proton Pump Inhibitors Issues and Proposed Guidelines. Digestion. 2009; 80: 226-34.
  21. Katz P.O., Gerson L.B., Vela M.F. Guidelines for the Diagnosis and Management of Gastroesophageal Reflux DiseaseThe American. J.Gastroenterol. 2013; 108: 308-28.
  22. Inadomi J.M. PPI use in the OTC era: who to treat, with what, and for how long? Clin Gastroenterol Hepatol. 2005; 3(3): 208-15.
  23. Besancon M., Simon A., Sachs G. Sites of reaction of the gastric H,K-ATPase with extra-cytoplasmic thiol reagents. J.Biol. Chem. 1997; 272(36): 22438-46.
  24. Morii M., Takata H., Fujisaki H. The potency of substituted benzimidazoles such as E3810, omeprazole, Ro 18-5364 to inhibit gastric H+, K(+)-ATPase is correlatedwith the rate of acid-activation of the inhibitor. Biochem Pharmacol. 1990; 39(4): 661-67.
  25. Лопина О.Д. Физиология протонной помпы. Росс. журнал гастроэнтерол., гепатол., колопроктол. 1997; 5: 91-6.
  26. Barnett J.L., Robinson M. Optimizing acid-suppression therapy. Manag Care. 2001; 10: 17-21.
  27. Bytzer P., Blum A., De Herdt D. Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease. Aliment Pharmacol Ther. 2004; 20(2): 181-88.
  28. Marshall R. Effect of omeprazole 20 mg twice daily on duodenogastric and gastro-oesophageal bile reflux in Barrett's oesophagus. Gut. 1998; 43(5): 603-06.
  29. Simonian H. Regional Postprandial Differences in pH Within the Stomach and Gastroesophageal Junction. Digestive Diseases and Sciences. 2005; 50(12): 2276-85.
  30. Клиническая фармакология. Национальное руководство / Под редакцией Ю. Белоусова. М., 2014. 976 с.
  31. Horn J. Review article: relationship between the metabolism and efficacy of proton pump inhibitors-focus on rabeprazole. Aliment Pharmacol. Ther. 2004; 6: 9-11.
  32. Dent J. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut. 2004; 53: 1-24.
  33. Vasiliadis K.V., Viazis N., Vlachogiannakos J., et al. Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system. Am. J. Gastroenterol. 2010; 105(2): 308-13.
  34. Joshua P Cohen, et al. Switching prescription drugs to over the counter. BMJ. 2005; 330(7481): 39-41

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>